{
  "id": "cluster_4_doc4",
  "content": "Research brief: 2023 Clarkston Valley case study of prion-autoimmune comorbidity (0.017% prevalence). Notable for faster disease progression than single-pathology cases. Insurance records show 82% denial rate for first-line therapies. Ethical review pending for experimental protocol NR-882.",
  "metadata": {
    "format": "research_note"
  }
}